11 'breakthrough' drug designations granted in US, 10 applications denied and 14 pending
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has so far granted 11 "breakthrough therapy" designations under the agency's new programme for expediting the development and review processes for medicines intended to treat serious or life-threatening diseases.